BioNeutra Global Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was CAD 3.15 million compared to CAD 3.59 million a year ago. Net loss was CAD 1.24 million compared to CAD 0.595951 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.01 a year ago. Diluted loss per share from continuing operations was CAD 0.03 compared to CAD 0.01 a year ago.
For the six months, sales was CAD 6.15 million compared to CAD 7.52 million a year ago. Net loss was CAD 2.16 million compared to CAD 0.480034 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.01 a year ago. Diluted loss per share from continuing operations was CAD 0.05 compared to CAD 0.01 a year ago.